Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: New tricks for old dogs

With the resurgence of the coronavirus pandemic, the repositioning of FDA-approved drugs against coronovirus and finding alternative strategies for antiviral therapy are both important. We previously identified the viral lipid envelope as a potential target for the prevention and treatment of SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Shekunov, Egor V., Zlodeeva, Polina D., Efimova, Svetlana S., Muryleva, Anna A., Zarubaev, Vladimir V., Slita, Alexander V., Ostroumova, Olga S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977712/
https://www.ncbi.nlm.nih.gov/pubmed/36868316
http://dx.doi.org/10.1016/j.antiviral.2023.105575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977712/
https://www.ncbi.nlm.nih.gov/pubmed/36868316
http://dx.doi.org/10.1016/j.antiviral.2023.105575

Ejemplares similares